{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:53:55Z","timestamp":1785426835091,"version":"3.56.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T00:00:00Z","timestamp":1356134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Cell"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s13238-012-2067-9","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T12:50:08Z","timestamp":1357303808000},"page":"71-81","source":"Crossref","is-referenced-by-count":28,"title":["Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma"],"prefix":"10.1093","volume":"4","author":[{"given":"Yun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,22]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2893.2004.00521.x","volume":"11","author":"M. Anzola","year":"2004","unstructured":"Anzola, M. (2004). Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 11, 383\u2013393.","journal-title":"J Viral Hepat"},{"key":"2067_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.onc.1205015","volume":"21","author":"N. Baptiste","year":"2002","unstructured":"Baptiste, N., Friedlander, P., Chen, X.B., and Prives, C. (2002). The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene 21, 9\u201321.","journal-title":"Oncogene"},{"key":"2067_CR3","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3748\/wjg.v16.i29.3603","volume":"16","author":"W. Blonski","year":"2010","unstructured":"Blonski, W., Kotlyar, D.S., and Forde, K.A. (2010). Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 16, 3603\u20133615.","journal-title":"World J Gastroenterol"},{"key":"2067_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/djj245","volume":"98","author":"B.J. Boersma","year":"2006","unstructured":"Boersma, B.J., Howe, T.M., Goodman, J.E., Yfantis, H.G., Lee, D.H., Chanock, S.J., and Ambs, S. (2006). Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst 98, 911\u2013919.","journal-title":"J Natl Cancer Inst"},{"key":"2067_CR5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","volume":"119","author":"G.L. Bond","year":"2004","unstructured":"Bond, G.L., Hu, W., Bond, E.E., Robins, H., Lutzker, S.G., Arva, N.C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591\u2013602.","journal-title":"Cell"},{"key":"2067_CR6","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","volume":"127","author":"C. Brechot","year":"2004","unstructured":"Brechot, C. (2004). Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127, S56\u201361.","journal-title":"Gastroenterology"},{"key":"2067_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J. Bruix","year":"2001","unstructured":"Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., Rodes, J., et al. (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepat 35, 421\u2013430.","journal-title":"J Hepat"},{"key":"2067_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/scbi.2000.0319","volume":"10","author":"M.A. Buendia","year":"2000","unstructured":"Buendia, M.A. (2000). Genetics of hepatocellular carcinoma. Semin Cancer Biol 10, 185\u2013200.","journal-title":"Semin Cancer Biol"},{"key":"2067_CR9","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1158\/1078-0432.CCR-08-3120","volume":"15","author":"D.W. Cescon","year":"2009","unstructured":"Cescon, D.W., Bradbury, P.A., Asomaning, K., Hopkins, J., Zhai, R., Zhou, W., Wang, Z., Kulke, M., Su, L., Ma, C., et al. (2009). p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 15, 3103\u20133109.","journal-title":"Clin Cancer Res"},{"key":"2067_CR10","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/hep.23943","volume":"52","author":"R.J. Clifford","year":"2010","unstructured":"Clifford, R.J., Zhang, J., Meerzaman, D.M., Lyu, M.-S., Hu, Y., Cultraro, C.M., Finney, R.P., Kelley, J.M., Efroni, S., Greenblum, S.I., et al. (2010). Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology 52, 2034\u20132043.","journal-title":"Hepatology"},{"key":"2067_CR11","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1158\/1078-0432.CCR-06-0111","volume":"12","author":"N. Dharel","year":"2006","unstructured":"Dharel, N., Kato, N., Muroyama, R., Moriyama, M., Shao, R.X., Kawabe, T., and Omata, M. (2006). MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C. Clin Cancer Res 12, 4867\u20134871.","journal-title":"Clin Cancer Res"},{"key":"2067_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P. Dumont","year":"2003","unstructured":"Dumont, P., Leu, J.I.J., Della Pietra, A.C., George, D.L., and Murphy, M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33, 357\u2013365.","journal-title":"Nat Genet"},{"key":"2067_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ijc.11254","volume":"106","author":"Y. Edamoto","year":"2003","unstructured":"Edamoto, Y., Hara, A., Biernat, W., Terracciano, L., Cathomas, G., Riehle, H.M., Matsuda, M., Fujii, H., Scoazec, J.Y., and Ohgaki, H. (2003). Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer Suppl 106, 334\u2013341.","journal-title":"Int J Cancer Suppl"},{"key":"2067_CR14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","volume":"7","author":"H.A. Edmondson","year":"1954","unstructured":"Edmondson, H.A., and Steiner, P.E. (1954). Primary Carcinoma of the Liver - a Study of 100 Cases among 48,900 Necropsies. Cancer 7, 462\u2013503.","journal-title":"Cancer"},{"key":"2067_CR15","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"H.B. El-Serag","year":"2007","unstructured":"El-Serag, H.B., and Rudolph, K.L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576.","journal-title":"Gastroenterology"},{"key":"2067_CR16","doi-asserted-by":"crossref","first-page":"a001032","DOI":"10.1101\/cshperspect.a001032","volume":"2","author":"L.F. Grochola","year":"2010","unstructured":"Grochola, L.F., Zeron-Medina, J., Meriaux, S., and Bond, G.L. (2010). Single-nucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol 2, a001032.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2067_CR17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.23668","volume":"113","author":"J.Y. Han","year":"2008","unstructured":"Han, J.Y., Lee, G.K., Jang, D.H., Lee, S.Y., and Lee, J.S. (2008). Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. Cancer 113, 799\u2013807.","journal-title":"Cancer"},{"key":"2067_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y. Haupt","year":"1997","unstructured":"Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296\u2013299.","journal-title":"Nature"},{"key":"2067_CR19","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1073\/pnas.88.20.9248","volume":"88","author":"O. Hino","year":"1991","unstructured":"Hino, O., Tabata, S., and Hotta, Y. (1991). Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. Proc Natl Acad Sci U S A 88, 9248\u20139252.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2067_CR20","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/1078-0432.CCR-07-0609","volume":"13","author":"H. Hirata","year":"2007","unstructured":"Hirata, H., Hinoda, Y., Kikuno, N., Kawamoto, K., Suehiro, Y., Tanaka, Y., and Dahiya, R. (2007). MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res 13, 4123\u20134129.","journal-title":"Clin Cancer Res"},{"key":"2067_CR21","first-page":"49","volume":"20","author":"Y. Horikawa","year":"2008","unstructured":"Horikawa, Y., Nadaoka, J., Saito, M., Kumazawa, T., Inoue, T., Yuasa, T., Tsuchiya, N., Nishiyama, H., Ogawa, O., and Habuchi, T. (2008). Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncol Rep 20, 49\u201355.","journal-title":"Oncol Rep"},{"key":"2067_CR22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","volume":"118","author":"J.H. Kao","year":"2000","unstructured":"Kao, J.H., Chen, P.J., Lai, M.Y., and Chen, D.S. (2000). Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118, 554\u2013559.","journal-title":"Gastroenterology"},{"key":"2067_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"M.H. Kubbutat","year":"1997","unstructured":"Kubbutat, M.H., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299\u2013303.","journal-title":"Nature"},{"key":"2067_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1479-666X(05)80043-5","volume":"3","author":"E.C. Lai","year":"2005","unstructured":"Lai, E.C., and Lau, W.Y. (2005). The continuing challenge of hepatic cancer in Asia. Surgeon 3, 210\u2013215.","journal-title":"Surgeon"},{"key":"2067_CR25","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3748\/wjg.15.5592","volume":"15","author":"J.D. Leu","year":"2009","unstructured":"Leu, J.D., Lin, I.F., Sun, Y.F., Chen, S.M., Liu, C.C., and Lee, Y.J. (2009). Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population. World J Gastroenterol 15, 5592\u20135597.","journal-title":"World J Gastroenterol"},{"key":"2067_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11373-007-9225-8","volume":"15","author":"C.L. Lin","year":"2008","unstructured":"Lin, C.L., and Kao, J.H. (2008). Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 15, 137\u2013145.","journal-title":"J Biomed Sci"},{"key":"2067_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1276646","volume":"31","author":"J.C. Nault","year":"2011","unstructured":"Nault, J.C., and Zucman-Rossi, J. (2011). Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 31, 173\u2013187.","journal-title":"Semin Liver Dis"},{"key":"2067_CR28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","volume":"52","author":"C. Neuveut","year":"2010","unstructured":"Neuveut, C., Wei, Y., and Buendia, M.A. (2010). Mechanisms of HBV-related hepatocarcinogenesis. J Hepat 52, 594\u2013604.","journal-title":"J Hepat"},{"key":"2067_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"D.M. Parkin","year":"2001","unstructured":"Parkin, D.M. (2001). Global cancer statistics in the year 2000. Lancet Oncol 2, 533\u2013543.","journal-title":"Lancet Oncol"},{"key":"2067_CR30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A. Petitjean","year":"2007","unstructured":"Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S.V., Hainaut, P., and Olivier, M. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human Mutat 28, 622\u2013629.","journal-title":"Human Mutat"},{"key":"2067_CR31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.11548","volume":"108","author":"D. Pim","year":"2004","unstructured":"Pim, D., and Banks, L. (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108, 196\u2013199.","journal-title":"Int J Cancer"},{"key":"2067_CR32","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.92.5.1342","volume":"92","author":"A. Puisieux","year":"1995","unstructured":"Puisieux, A., Ji, J., Guillot, C., Legros, Y., Soussi, T., Isselbacher, K., and Ozturk, M. (1995). p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus. Proc Natl Acad Sci U S A 92, 1342\u20131346.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2067_CR33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2005-871194","volume":"25","author":"M. Sherman","year":"2005","unstructured":"Sherman, M. (2005). Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25, 143\u2013154.","journal-title":"Semin Liver Dis"},{"key":"2067_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/gast.1996.v111.pm8698200","volume":"111","author":"E. Silini","year":"1996","unstructured":"Silini, E., Bottelli, R., Asti, M., Bruno, S., Candusso, M.E., Brambilla, S., Bono, F., Iamoni, G., Tinelli, C., Mondelli, M.U., et al. (1996). Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 111, 199\u2013205.","journal-title":"Gastroenterology"},{"key":"2067_CR35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.22339","volume":"120","author":"B.A. Talseth","year":"2007","unstructured":"Talseth, B.A., Meldrum, C., Suchy, J., Kurzawski, G., Lubinski, J., and Scott, R.J. (2007). MDM2 SNP309 T > G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer 120, 563\u2013565.","journal-title":"Int J Cancer"},{"key":"2067_CR36","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/1078-0432.CCR-08-2249","volume":"15","author":"G. Toffoli","year":"2009","unstructured":"Toffoli, G., Biason, P., Russo, A., De Mattia, E., Cecchin, E., Hattinger, C.M., Pasello, M., Alberghini, M., Ferrari, C., Scotlandi, K., et al. (2009). Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res 15, 3550\u20133556.","journal-title":"Clin Cancer Res"},{"key":"2067_CR37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-10-147","volume":"10","author":"M. Xiao","year":"2010","unstructured":"Xiao, M., Zhang, L., Zhu, X., Huang, J., Jiang, H., Hu, S., and Liu, Y. (2010). Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population. BMC cancer 10, 147.","journal-title":"BMC cancer"},{"key":"2067_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e3181904988","volume":"249","author":"L.Y. Yang","year":"2009","unstructured":"Yang, L.Y., Fang, F., Ou, D.P., Wu, W., Zeng, Z.J., and Wu, F. (2009). Solitary large hepatocellular carcinoma a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 249, 118\u2013123.","journal-title":"Ann Surg"},{"key":"2067_CR39","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/carcin\/bgn090","volume":"29","author":"Y.J. Yoon","year":"2008","unstructured":"Yoon, Y.J., Chang, H.Y., Ahn, S.H., Kim, J.K., Park, Y.K., Kang, D.R., Park, J.Y., Myoung, S.M., Kim do, Y., Chon, C.Y., et al. (2008). MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 29, 1192\u20131196.","journal-title":"Carcinogenesis"},{"key":"2067_CR40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","volume":"24","author":"M.F. Yuen","year":"2009","unstructured":"Yuen, M.F., Hou, J.L., Chutaputti, A., and Asia Pacific Working Party on Prevention of Hepatocellular, C. (2009). Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepat 24, 346\u2013353.","journal-title":"J Gastroenterol Hepat"},{"key":"2067_CR41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/humu.20277","volume":"27","author":"X. Zhang","year":"2006","unstructured":"Zhang, X., Miao, X., Guo, Y., Tan, W., Zhou, Y., Sun, T., Wang, Y., and Lin, D. (2006). Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Human Mutat 27, 110\u2013117.","journal-title":"Human Mutat"}],"container-title":["Protein &amp; Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-012-2067-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13238-012-2067-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-012-2067-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:40:25Z","timestamp":1676374825000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/proteincell\/article\/4\/1\/71\/6874323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,22]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s13238-012-2067-9","relation":{},"ISSN":["1674-800X","1674-8018"],"issn-type":[{"value":"1674-800X","type":"print"},{"value":"1674-8018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,22]]}}}